The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 trial of NBTXR3 nanoparticles activated by intensity-modulated radiation therapy (IMRT) in the treatment of advanced-stage head and neck squamous cell carcinoma (HNSCC).
 
Christophe Le Tourneau
Honoraria - Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Debiopharm Group; GamaMabs Pharma
Travel, Accommodations, Expenses - Merck Serono; MSD
 
Valentin Calugaru
Honoraria - Nanobiotix
 
Thomas Jouffroy
No Relationships to Disclose
 
Jose Rodriguez
No Relationships to Disclose
 
Caroline Hoffmann
No Relationships to Disclose
 
Bernard Dodger
No Relationships to Disclose
 
Victor Moreno
No Relationships to Disclose
 
Emiliano Calvo
Consulting or Advisory Role - Astellas Pharma; GlaxoSmithKline; Lilly/ImClone; Nanobiotix; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Novartis
Research Funding - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Janssen Oncology; Lilly; Merck; Millennium; Nektar; Novartis; OncoMed; Pfizer; PharmaMar; PsiOxus Therapeutics; Puma Biotechnology; Roche/Genentech; Sanofi; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Lilly; Novartis; PsiOxus Therapeutics
Other Relationship - Pierre Fabre